Nanocarriers significantly augment the absorption of ocular-delivered drugs: A comparative meta-analysis study

Int J Pharm. 2023 Jul 25:642:123204. doi: 10.1016/j.ijpharm.2023.123204. Epub 2023 Jul 3.

Abstract

This study presents a meta-analysis that compiles information collected from several studies aiming to prove, by evidence, that nanocarriers out-perform conventional formulations in augmenting the bioavailability of ocular topically administered drugs. Data was further categorized into two subgroups; polymeric-based nanocarriers versus their lipid-based counterparts, as well as, naturally-driven carriers versus synthetically-fabricated ones. After normalization, the pharmacokinetic factor, area under the curve (AUC), was denoted as the "effect" in the conducted study, and the corresponding Forest plots were obtained. Our meta-analysis study confirmed the absorption enhancement effect of loading drugs into nanocarriers as compared to conventional topical ocular dosage forms. Interestingly, no significant differences were recorded between the polymeric and lipidic nanocarriers included in the study, while naturally-driven nanoplatforms were proven superior to the synthetic alternatives.

Keywords: AUC; Forest; Lipidic nanocarriers; Meta-analysis; Natural; Ocular drug delivery; Polymeric nanocarriers; Synthetic; Topical.

Publication types

  • Meta-Analysis

MeSH terms

  • Drug Carriers*
  • Drug Delivery Systems
  • Nanoparticles*
  • Polymers

Substances

  • Drug Carriers
  • Polymers